Miss our 2020 MIPS Reporting Webinar on 10/22? Click here to play it back!

2020 MIPS Quality Benchmarks

What Are Quality Measure Benchmarks?

When a clinician or group submits measures for the Merit-based Incentive Payment System (MIPS) quality performance category, each measure is assessed against its benchmark to determine how many points the measure earns. In program year 2020, a clinician or group can receive anywhere from 3 to 10 points* for each MIPS measure (not including any bonus points) that meets the data completeness standards and case minimum requirements through Benchmarks. Benchmarks are specific to the collection type: Qualified Clinical Data Registry (QCDR) measures, MIPS Clinical Quality Measures (MIPS CQMs)*, eCQMs, CMS Web Interface measures, the Consumer Assessment of Healthcare Providers and Systems (CAHPS) for MIPS survey, and Part B Claims measures. In order to measure performance that is comparable across the spectrum of performance, benchmarks are established using historical data. Historical benchmarks are based on actual performance data from 2018 that was submitted to the Quality Payment Program (QPP) in 2018.  *MIPS CQMs are measures submitted using registry rules.

How Are Benchmarks Displayed?

Each benchmark is presented in terms of deciles. Points will be awarded within each decile (see table below). Clinicians who receive a score in the first or second decile will receive 3 points. Clinicians who are in the 3rd decile will receive somewhere between 3 and 3.9 points depending on their exact position in the decile, and clinicians in higher deciles will receive a corresponding number of points. For example, if a clinician submits performance data of 83% on a non-inverse measure, and the 5th decile begins at 72% and the 6th decile begins at 85%, then the clinician will receive between 5 and 5.9 points because 83% is in the 5th decile. For inverse measures where a higher performance is seen by a lower number on the performance score, the scores are reversed in the benchmark deciles (example: Measure 1). An Excel version of the 2020 MIPS Quality Historical Benchmarks can be found here

*Measures marked in blue (example: Measure 130) can only earn a maximum score of 7 points.  There are 61 Measures that meet this description.  Topped-out means that the national median performance rate is so high that there is no meaningful difference in performance between clinicians.

 

Measure NameMeasure IDCollection TypeDecile 3Decile 4Decile 5Decile 6Decile 7Decile 8Decile 9Decile 10
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)1MIPS CQM79.99 - 70.0170 - 60.0160 - 50.0150 - 40.0140 - 30.0130 - 20.0119 - 10.01<= 10
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)1eCQM<= 99.4699.45 - 92.6292.61 - 74.4874.47 - 59.0959.08 - 46.8546.84 - 37.8937.88 - 31.41<=31.4
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)1Medicare Part B Claims79.99 - 70.0170 - 60.0160 - 50.0150 - 40.0140 - 30.0130 - 20.0119 - 10.01<= 10
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)5eCQM21.9 - 59.5759.58 - 71.571.51 - 80.4780.48 - 87.8687.87 - 95.2295.23 - 99.99--100
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)5MIPS CQM45.19 - 68.568.51 - 82.3482.35 - 94.3494.35 - 99.99------100
Coronary Artery Disease (CAD): Antiplatelet Therapy6MIPS CQM11.82 - 74.7574.76 - 86.3786.38 - 93.7493.75 - 98.6298.63 - 99.99----100
Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)7eCQM37.83 - 70.7770.78 - 80.4580.46 - 86.7286.73 - 91.6591.66 - 95.3795.38 - 97.1297.13 - 99.99100
Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)7MIPS CQM60.6 - 82.7482.75 - 89.3489.35 - 94.1894.19 - 97.797.71 - 99.99----100
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)8eCQM27.53 - 69.9970 - 81.5881.59 - 89.5489.55 - 94.3294.33 - 97.2197.22 - 99.99--100
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)8MIPS CQM61.82 - 85.785.71 - 92.7492.75 - 97.2397.24 - 99.99100   
Anti-Depressant Medication Management9eCQM2.55 - 18.418.41 - 32.5332.54 - 49.3449.35 - 64.5964.6 - 90.1190.12 - 93.0793.08 - 98.96>=98.97
Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation12Medicare Part B Claims52.58 - 97.3597.36 - 99.99----100   
Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation12eCQM2.93 - 66.6566.66 - 84.7284.73 - 93.993.91 - 98.2598.26 - 99.6999.7 - 99.99--100
Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation12MIPS CQM28.48 - 84.4884.49 - 96.9696.97 - 99.99--100   
Age-Related Macular Degeneration (AMD): Dilated Macular Examination14Medicare Part B Claims27.65 - 92.4692.47 - 99.99----100   
Age-Related Macular Degeneration (AMD): Dilated Macular Examination14MIPS CQM3.45 - 60.7760.78 - 86.9186.92 - 96.9296.93 - 99.999.91 - 100   
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care19eCQM2.79 - 35.5335.54 - 65.465.41 - 86.4986.5 - 96.6596.66 - 99.8799.88 - 99.99--100
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care19MIPS CQM3.12 - 38.7638.77 - 82.782.71 - 98.6398.64 - 99.99100   
Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second-Generation Cephalosporin21Medicare Part B Claims6.46 - 94.694.61 - 99.99----100   
Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second-Generation Cephalosporin21MIPS CQM0.43 - 57.0857.09 - 97.5397.54 - 99.99--100   
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)23Medicare Part B Claims2.92 - 98.6398.64 - 99.99----100   
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)23MIPS CQM0.95 - 79.8379.84 - 98.5198.52 - 99.99--100   
Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older24Medicare Part B Claims3.74 - 61.4961.5 - 92.1492.15 - 99.3499.35 - 99.99100   
Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older24MIPS CQM2.48 - 12.8812.89 - 45.4445.45 - 76.9676.97 - 98.4498.45 - 99.99----100
Screening for Osteoporosis for Women Aged 65-85 Years of Age39Medicare Part B Claims3.19 - 23.8423.85 - 41.841.81 - 56.9656.97 - 74.3974.4 - 93.4993.5 - 99.3799.38 - 99.99100
Screening for Osteoporosis for Women Aged 65-85 Years of Age39MIPS CQM0.28 - 33.01 - 16.216.21 - 48.6548.66 - 76.9977 - 94.4294.43 - 99.5399.54 - 99.99100
Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery44MIPS CQM58.73 - 91.7391.74 - 97.5597.56 - 99.99--100   
Advance Care Plan47Medicare Part B Claims0.65 - 18.1718.18 - 74.8674.87 - 98.7398.74 - 99.99100   
Advance Care Plan47MIPS CQM0.14 - 4.074.08 - 36.1436.15 - 82.8382.84 - 98.2798.28 - 99.99----100
Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older48Medicare Part B Claims0.33 - 1.281.29 - 5.025.03 - 98.4198.42 - 99.99100   
Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older48MIPS CQM0.43 - 4.194.2 - 28.3428.35 - 79.2479.25 - 99.1299.13 - 99.99----100
Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older50Medicare Part B Claims19.04 - 65.5365.54 - 96.7696.77 - 99.99--100   
Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older50MIPS CQM3.56 - 25.6425.65 - 54.0154.02 - 79.1579.16 - 96.2896.29 - 99.99----100
Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator Therapy52Medicare Part B Claims44.62 - 93.2693.27 - 99.99----100   
Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator Therapy52MIPS CQM36.47 - 62.4962.5 - 79.379.31 - 97.4997.5 - 99.99100   
Appropriate Treatment for Children with Upper Respiratory Infection (URI)65eCQM25.66 - 75.9375.94 - 86.7986.8 - 93.3993.4 - 97.0497.05 - 99.99----100
Appropriate Treatment for Children with Upper Respiratory Infection (URI)65MIPS CQM59.39 - 89.0789.08 - 94.6194.62 - 98.7198.72 - 99.99100   
Appropriate Testing for Children with Pharyngitis66eCQM0.51 - 17.6917.7 - 53.7153.72 - 77.0377.04 - 87.6887.69 - 93.5393.54 - 95.8295.83 - 99.99100
Appropriate Testing for Children with Pharyngitis66MIPS CQM19.27 - 56.1656.17 - 69.5969.6 - 81.9781.98 - 91.3891.39 - 95.9996 - 98.1798.18 - 99.99100
Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow67MIPS CQM3.67 - 8.578.58 - 23.2523.26 - 47.4947.5 - 99.7799.78 - 99.99----100
Hematology: Multiple Myeloma: Treatment with Bisphosphonates69MIPS CQM----------------
Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry70MIPS CQM2.82 - 6.966.97 - 10.710.71 - 45.4445.45 - 98.7498.75 - 99.99----100
Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections76Medicare Part B Claims12.38 - 91.8291.83 - 99.99----100   
Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections76MIPS CQM20.21 - 89.6289.63 - 97.9197.92 - 99.99--100   
Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy - Avoidance of Inappropriate Use93Medicare Part B Claims18.37 - 94.8194.82 - 99.99----100   
Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy - Avoidance of Inappropriate Use93MIPS CQM41.46 - 73.973.91 - 86.9486.95 - 95.8295.83 - 99.99------100
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients102eCQM----------------
Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients102MIPS CQM41.44 - 92.4892.49 - 99.99----------100
Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer104MIPS CQM25.51 - 61.561.51 - 92.3492.35 - 98.4798.48 - 99.99------100
Adult Major Depressive Disorder (MDD): Suicide Risk Assessment107eCQM0.05 - 0.740.75 - 5.185.19 - 30.2930.3 - 72.972.91 - 96.1396.14 - 99.1199.12 - 99.99100
Preventive Care and Screening: Influenza Immunization110Medicare Part B Claims1.1 - 16.1416.15 - 34.7634.77 - 72.8372.84 - 98.8298.83 - 99.99----100
Preventive Care and Screening: Influenza Immunization110eCQM0.11 - 3.343.35 - 16.9516.96 - 36.4936.5 - 58.458.41 - 81.0981.1 - 92.4192.42 - 99.99100
Preventive Care and Screening: Influenza Immunization110MIPS CQM0.21 - 11.4311.44 - 32.8232.83 - 61.6361.64 - 88.0788.08 - 99.4399.44 - 99.99--100
Pneumococcal Vaccination Status for Older Adults111Medicare Part B Claims1.05 - 40.6940.7 - 61.5661.57 - 81.181.11 - 95.3795.38 - 99.99----100
Pneumococcal Vaccination Status for Older Adults111eCQM0.15 - 4.444.45 - 24.1524.16 - 52.0652.07 - 75.2275.23 - 88.8188.82 - 95.0395.04 - 99.99100
Pneumococcal Vaccination Status for Older Adults111MIPS CQM0.35 - 13.7813.79 - 43.4343.44 - 68.7968.8 - 82.1282.13 - 93.7493.75 - 99.3799.38 - 99.99100
Breast Cancer Screening112Medicare Part B Claims3.12 - 28.6328.64 - 57.1357.14 - 75.9375.94 - 94.9694.97 - 99.99----100
Breast Cancer Screening112eCQM0.28 - 7.37.31 - 27.2827.29 - 51.5551.56 - 69.3569.36 - 81.4781.48 - 88.2688.27 - 98.54>=98.55
Breast Cancer Screening112MIPS CQM0.43 - 7.557.56 - 27.8727.88 - 55.6955.7 - 77.5577.56 - 92.6392.64 - 99.99--100
Colorectal Cancer Screening113MIPS CQM----------------
Colorectal Cancer Screening113Medicare Part B Claims----------------
Colorectal Cancer Screening113eCQM0.13 - 2.582.59 - 19.3319.34 - 45.6345.64 - 7070.01 - 84.4984.5 - 90.8190.82 - 99.38>=99.39
Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis116MIPS CQM6.61 - 37.4937.5 - 55.355.31 - 81.4881.49 - 98.7198.72 - 99.99----100
Diabetes: Eye Exam117Medicare Part B Claims3.32 - 25.7925.8 - 91.0491.05 - 99.99--100   
Diabetes: Eye Exam117eCQM0.6 - 6.836.84 - 21.221.21 - 49.9950 - 97.3797.38 - 99.8499.85 - 99.99--100
Diabetes: Eye Exam117MIPS CQM0.61 - 23.2923.3 - 80.6880.69 - 97.8397.84 - 99.99100   
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)118MIPS CQM34.59 - 71.4171.42 - 77.7977.8 - 84.184.11 - 89.8189.82 - 97.4697.47 - 99.99--100
Diabetes: Medical Attention for Nephropathy119eCQM4.17 - 53.5653.57 - 71.4171.42 - 83.4683.47 - 9292.01 - 97.9497.95 - 99.6399.64 - 99.99100
Diabetes: Medical Attention for Nephropathy119MIPS CQM5.77 - 57.8657.87 - 77.1477.15 - 87.3287.33 - 98.1898.19 - 99.99----100
Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy - Neurological Evaluation126MIPS CQM0.58 - 26.7926.8 - 66.6166.62 - 91.6991.7 - 99.99------100
Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention - Evaluation of Footwear127MIPS CQM0.48 - 22.5822.59 - 58.6658.67 - 89.9289.93 - 99.99------100
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan128Medicare Part B Claims15.33 - 32.5932.6 - 64.3364.34 - 99.0799.08 - 99.99100   
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan128eCQM0.42 - 17.4717.48 - 23.8823.89 - 37.3837.39 - 73.9673.97 - 94.1494.15 - 98.3598.36 - 99.99100
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan128MIPS CQM4.22 - 22.922.91 - 40.9941 - 83.8583.86 - 98.3598.36 - 99.99----100
Documentation of Current Medications in the Medical Record130Medicare Part B Claims13.26 - 93.3893.39 - 99.3299.33 - 99.99--100   
Documentation of Current Medications in the Medical Record130eCQM6.46 - 66.0166.02 - 88.8188.82 - 97.3497.35 - 99.6899.69 - 100   
Documentation of Current Medications in the Medical Record130MIPS CQM3.07 - 43.6743.68 - 94.6494.65 - 99.6899.69 - 99.99100   
Preventive Care and Screening: Screening for Depression and Follow-Up Plan134Medicare Part B Claims0.17 - 0.880.89 - 45.4945.5 - 99.5499.55 - 99.99100   
Preventive Care and Screening: Screening for Depression and Follow-Up Plan134eCQM0.08 - 1.821.83 - 8.038.04 - 26.7326.74 - 65.265.21 - 88.688.61 - 95.6595.66 - 99.99100
Preventive Care and Screening: Screening for Depression and Follow-Up Plan134MIPS CQM0.04 - 2.822.83 - 27.5827.59 - 74.3974.4 - 96.1896.19 - 99.99----100
Melanoma: Continuity of Care - Recall System137MIPS CQM3.95 - 67.3167.32 - 95.2995.3 - 99.99--------100
Melanoma: Coordination of Care138MIPS CQM2.13 - 25.625.61 - 72.1672.17 - 99.99--------100
Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care141Medicare Part B Claims37.12 - 96.696.61 - 99.99----------100
Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care141MIPS CQM0.29 - 9.159.16 - 17.4517.46 - 26.6526.66 - 82.0282.03 - 99.9699.97 - 99.99--100
Oncology: Medical and Radiation - Pain Intensity Quantified143eCQM2.27 - 47.9747.98 - 84.6284.63 - 95.9495.95 - 99.0599.06 - 100   
Oncology: Medical and Radiation - Pain Intensity Quantified143MIPS CQM4.15 - 67.4467.45 - 93.0893.09 - 99.5299.53 - 99.99100   
Oncology: Medical and Radiation - Plan of Care for Moderate to Severe Pain144MIPS CQM----------------
Radiology: Exposure Dose Indices or Exposure Time and Number of Images Reported for Procedures Using Fluoroscopy145Medicare Part B Claims4.25 - 58.7558.76 - 91.1691.17 - 98.698.61 - 99.99100   
Radiology: Exposure Dose Indices or Exposure Time and Number of Images Reported for Procedures Using Fluoroscopy145MIPS CQM3.3 - 47.4447.45 - 86.4486.45 - 98.5698.57 - 99.99100   
Radiology: Inappropriate Use of "Probably Benign" Assessment Category in Screening Mammograms146Medicare Part B Claims4.15 - 0.50.49 - 0.190.18 - 0.01--------0
Radiology: Inappropriate Use of "Probably Benign" Assessment Category in Screening Mammograms146MIPS CQM5.57 - 0.660.65 - 0.250.24 - 0.110.1 - 0.040.03 - 0.01----0
Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy147Medicare Part B Claims12.11 - 61.8961.9 - 92.2992.3 - 99.99--100   
Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy147MIPS CQM29.25 - 77.3677.37 - 95.2295.23 - 99.99--100   
Falls: Risk Assessment154Medicare Part B Claims7.43 - 89.1489.15 - 99.99----100   
Falls: Risk Assessment154MIPS CQM3.33 - 31.1631.17 - 78.3778.38 - 98.598.51 - 99.99100   
Falls: Plan of Care155Medicare Part B Claims1.4 - 28.6328.64 - 99.99----100   
Falls: Plan of Care155MIPS CQM1.94 - 26.7126.72 - 70.170.11 - 94.7894.79 - 99.99------100
Coronary Artery Bypass Graft (CABG): Prolonged Intubation164MIPS CQM31.14 - 13.5613.55 - 11.3611.35 - 8.728.71 - 6.86.79 - 5.835.82 - 4.74.69 - 3.94<= 3.93
Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure167MIPS CQM7.36 - 3.793.78 - 2.942.93 - 2.272.26 - 1.811.8 - 1.331.32 - 0.920.91 - 0.010
Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration168MIPS CQM10.93 - 5.935.92 - 4.084.07 - 3.243.23 - 2.312.3 - 1.791.78 - 1.231.22 - 0.9<= 0.89
Rheumatoid Arthritis (RA): Tuberculosis Screening176MIPS CQM2.04 - 27.9327.94 - 52.7952.8 - 89.1489.15 - 99.99------100
Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity177MIPS CQM----------------
Rheumatoid Arthritis (RA): Functional Status Assessment178MIPS CQM3.05 - 45.4645.47 - 82.2282.23 - 95.5695.57 - 99.99100   
Rheumatoid Arthritis (RA): Glucocorticoid Management180MIPS CQM2.92 - 40.8940.9 - 68.2368.24 - 87.287.21 - 98.9198.92 - 99.99----100
Elder Maltreatment Screen and Follow-Up Plan181Medicare Part B Claims0.25 - 12.1912.2 - 99.4899.49 - 99.99--100   
Elder Maltreatment Screen and Follow-Up Plan181MIPS CQM0.56 - 27.7427.75 - 67.7467.75 - 92.0592.06 - 99.99------100
Functional Outcome Assessment182Medicare Part B Claims0.21 - 88.988.91 - 99.9399.94 - 99.99--100   
Functional Outcome Assessment182MIPS CQM0.18 - 1.381.39 - 5.665.67 - 87.1287.13 - 99.6699.67 - 99.99----100
Colonoscopy Interval for Patients with a History of Adenomatous Polyps - Avoidance of Inappropriate Use185MIPS CQM1.6 - 27.2627.27 - 71.7571.76 - 98.0398.04 - 99.99100   
Stroke and Stroke Rehabilitation: Thrombolytic Therapy187MIPS CQM11.43 - 53.1153.12 - 79.2479.25 - 97.2897.29 - 99.99100   
Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery191eCQM11.89 - 66.8666.87 - 87.1787.18 - 96.1496.15 - 98.8698.87 - 99.99----100
Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery191MIPS CQM55.45 - 87.7187.72 - 95.0695.07 - 98.998.91 - 99.99100   
Radiology: Stenosis Measurement in Carotid Imaging Reports195Medicare Part B Claims39.7 - 90.5590.56 - 98.4898.49 - 99.99--100   
Radiology: Stenosis Measurement in Carotid Imaging Reports195MIPS CQM48.4 - 93.5193.52 - 98.9798.98 - 99.99--100   
HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis205MIPS CQM----------------
Functional Status Change for Patients with Knee Impairments217MIPS CQM----------------
Functional Status Change for Patients with Hip Impairments218MIPS CQM----------------
Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairments219MIPS CQM----------------
Functional Status Change for Patients with Low Back Impairments220MIPS CQM----------------
Functional Status Change for Patients with Shoulder Impairments221MIPS CQM----------------
Functional Status Change for Patients with Elbow, Wrist or Hand Impairments222MIPS CQM----------------
Radiology: Reminder System for Screening Mammograms225Medicare Part B Claims3.45 - 99.1699.17 - 99.99----------100
Radiology: Reminder System for Screening Mammograms225MIPS CQM29.83 - 99.99------------100
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention226Medicare Part B Claims66.66 - 95.8595.86 - 99.2999.3 - 99.99--------100
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention226eCQM0.93 - 7.267.27 - 24.1524.16 - 73.9773.98 - 90.2890.29 - 97.197.11 - 99.99--100
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention226MIPS CQM1.88 - 10.4510.46 - 25.4825.49 - 65.6965.7 - 97.6697.67 - 99.99----100
Controlling High Blood Pressure236Medicare Part B Claims20 - 29.9930 - 39.9940 - 49.9950 - 59.9960 - 69.9970 - 79.9980 - 89.99>= 90
Controlling High Blood Pressure236MIPS CQM20 - 29.9930 - 39.9940 - 49.9950 - 59.9960 - 69.9970 - 79.9980 - 89.99>= 90
Controlling High Blood Pressure236eCQM20 - 29.9930 - 39.9940 - 49.9950 - 59.9960 - 69.9970 - 79.9980 - 89.99>= 90
Use of High-Risk Medications in the Elderly238MIPS CQM27.17 - 13.4813.47 - 8.528.51 - 2.182.17 - 0.340.33 - 0.01----0
Use of High-Risk Medications in the Elderly238eCQM32.77- 16.9916.98 - 11.4911.48 - 4.44.39 - 0.580.57 - 0.01----0
Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents239eCQM0.46 - 21.7821.79 - 29.3429.35 - 33.3233.33 - 43.6943.7 - 71.4971.5 - 85.5385.54 - 99.39>=99.4
Childhood Immunization Status240eCQM0.95 - 5.255.26 - 15.0915.1 - 29.4129.42 - 40.6140.62 - 53.5553.56 - 60.1460.15 - 75.58>=75.59
Cardiac Rehabilitation Patient Referral from an Outpatient Setting243MIPS CQM0.5 - 2.622.63 - 7.277.28 - 20.7420.75 - 42.942.91 - 71.8171.82 - 88.1688.17 - 99.99100
Barrett's Esophagus249Medicare Part B Claims97.2 - 99.99------100   
Barrett's Esophagus249MIPS CQM71.31 - 99.8499.85 - 99.99----100   
Radical Prostatectomy Pathology Reporting250Medicare Part B Claims98.1 - 99.99------100   
Radical Prostatectomy Pathology Reporting250MIPS CQM98.78 - 99.99------100   
Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain254Medicare Part B Claims----------------
Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain254MIPS CQM57.55 - 80.3980.4 - 90.6190.62 - 96.2896.29 - 99.99------100
Rate of Open Repair of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7)258MIPS CQM----------------
Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post Operative Day #2)259MIPS CQM----------------
Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2)260MIPS CQM29.83 - 85.1185.12 - 88.1688.17 - 91.9391.94 - 97.1297.13 - 99.99----100
Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness261Medicare Part B Claims----------------
Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness261MIPS CQM----------------
Sentinel Lymph Node Biopsy for Invasive Breast Cancer264MIPS CQM89.01 - 95.3395.34 - 98.5998.6 - 99.99--100   
Biopsy Follow-Up265MIPS CQM0.66 - 25.3625.37 - 82.382.31 - 99.7899.79 - 99.99100   
Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy268Medicare Part B Claims----------------
Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy268MIPS CQM1.95 - 14.6714.68 - 28.8328.84 - 64.6964.7 - 95.4495.45 - 99.99----100
Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy275MIPS CQM----------------
Sleep Apnea: Severity Assessment at Initial Diagnosis277MIPS CQM0.36 - 5.685.69 - 38.8238.83 - 90.6190.62 - 99.99------100
Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy279MIPS CQM25.5 - 50.2950.3 - 80.6180.62 - 98.6698.67 - 99.99100   
Dementia: Cognitive Assessment281eCQM0.51 - 3.563.57 - 10.2710.28 - 43.8643.87 - 87.3387.34 - 98.5198.52 - 99.99--100
Dementia: Functional Status Assessment282MIPS CQM0.85 - 28.1528.16 - 70.5770.58 - 96.6596.66 - 99.99100   
Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management283MIPS CQM7.78 - 52.4452.45 - 89.7589.76 - 99.7699.77 - 99.99100   
Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia286MIPS CQM5.2 - 19.5519.56 - 56.0356.04 - 98.2898.29 - 99.99100   
Dementia: Education and Support of Caregivers for Patients with Dementia288MIPS CQM3.48 - 15.7215.73 - 44.8744.88 - 86.8386.84 - 99.99------100
Parkinson's Disease: Psychiatric Symptoms Assessment for Patients with Parkinson's Disease290MIPS CQM3.5 - 9.379.38 - 22.9422.95 - 51.8451.85 - 99.99------100
Parkinson's Disease: Cognitive Impairment or Dysfunction Assessment for Patients with Parkinson's Disease291MIPS CQM1.77 - 10.7810.79 - 56.456.41 - 99.99--100   
Parkinson's Disease: Rehabilitative Therapy Options293MIPS CQM3.7 - 24.6124.62 - 63.3263.33 - 95.6495.65 - 99.99100   
Cataracts: Improvement in Patient's Visual Function within 90 Days Following Cataract Surgery303MIPS CQM1.98 - 26.3526.36 - 42.9242.93 - 69.9669.97 - 96.7296.73 - 99.99----100
Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery304MIPS CQM1.6 - 20.1420.15 - 49.2749.28 - 75.7575.76 - 96.3996.4 - 99.99----100
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment305eCQM0.08 - 0.360.37 - 0.640.65 - 1.431.44 - 3.333.34 - 8.028.03 - 12.3612.37 - 39.07>=39.08
Cervical Cancer Screening309eCQM0.27 - 3.413.42 - 14.3714.38 - 32.0832.09 - 53.8653.87 - 73.9873.99 - 85.3585.36 - 96.91>=96.92
Chlamydia Screening for Women310eCQM0.91 - 6.886.89 - 19.0319.04 - 35.1235.13 - 50.5950.6 - 66.5366.54 - 72.1272.13 - 82.47>=82.48
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented317Medicare Part B Claims4.32 - 29.3429.35 - 55.7755.78 - 95.5795.58 - 99.99------100
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented317eCQM0.23 - 12.2412.25 - 21.921.91 - 31.431.41 - 43.443.41 - 61.5261.53 - 79.1779.18 - 99.99100
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented317MIPS CQM0.26 - 16.3916.4 - 33.2233.23 - 53.7353.74 - 91.591.51 - 99.99----100
Falls: Screening for Future Fall Risk318eCQM0.04 - 1.381.39 - 21.6721.68 - 65.2665.27 - 90.3590.36 - 98.1598.16 - 99.599.51 - 99.99100
Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients320Medicare Part B Claims17.34 - 86.886.81 - 95.2295.23 - 99.99--100   
Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients320MIPS CQM1.02 - 59.1359.14 - 85.3885.39 - 95.0995.1 - 99.0799.08 - 100   
CAHPS for MIPs Clinician/Group Survey321Certified Survey Vendor----------------
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients322MIPS CQM65.24 - 5.835.82 - 0.970.96 - 0.01--------0
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI)323MIPS CQM77.03 - 4.874.86 - 0.680.67 - 0.01--------0
Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients324MIPS CQM55.83 - 30.1630.15 - 20.920.89 - 2.782.77 - 0.01------0
Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy326Medicare Part B Claims48.19 - 93.1293.13 - 99.99----100   
Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy326MIPS CQM22.05 - 68.0668.07 - 79.579.51 - 95.0395.04 - 99.99------100
Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)331MIPS CQM100 - 97.3697.35 - 87.1387.12 - 76.0876.07 - 65.5765.56 - 54.2854.27 - 43.5943.58 - 34.3234.31 - 23.19
Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)332MIPS CQM15.68 - 58.1958.2 - 87.8287.83 - 98.0798.08 - 99.99100   
Adult Sinusitis: Computerized Tomography (CT) for Acute Sinusitis (Overuse)333MIPS CQM59.37 - 11.8511.84 - 6.366.35 - 1.821.81 - 0.01------0
Maternity Care: Elective Delivery or Early Induction Without Medical Indication at < 39 Weeks (Overuse)335MIPS CQM----------------
Maternity Care: Postpartum Follow-up and Care Coordination336MIPS CQM----------------
Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis on a Biological Immune Response Modifier337MIPS CQM3.69 - 27.5727.58 - 62.3362.34 - 90.4690.47 - 99.99------100
HIV Viral Load Suppression338MIPS CQM28.21 - 50.1950.2 - 77.9677.97 - 86.5986.6 - 97.4897.49 - 99.99----100
HIV Medical Visit Frequency340MIPS CQM9.49 - 40.6540.66 - 51.8851.89 - 70.270.21 - 92.1292.13 - 99.99----100
Pain Brought Under Control Within 48 Hours342MIPS CQM34.48 - 86.0686.07 - 99.99----------100
Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)344MIPS CQM----------------
Implantable Cardioverter-Defibrillator (ICD) Complications Rate348MIPS CQM----------------
Total Knee Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy350MIPS CQM22.86 - 89.5289.53 - 99.6499.65 - 99.99--100   
Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation351MIPS CQM8.82 - 92.4392.44 - 99.99----100   
Anastomotic Leak Intervention354MIPS CQM90.33 - 20.7820.77 - 8.348.33 - 3.233.22 - 0.01------0
Unplanned Reoperation within the 30 Day Postoperative Period355MIPS CQM82.57 - 10.1510.14 - 4.614.6 -2.222.21 - 0.360.35 - 0.01----0
Unplanned Hospital Readmission within 30 Days of Principal Procedure356MIPS CQM68.31 - 9.329.31 - 6.116.1 - 3.233.22 - 0.880.87 - 0.01----0
Surgical Site Infection (SSI)357MIPS CQM92.4 - 40.4640.45 - 5.535.52 - 1.671.66 - 0.01------0
Patient-Centered Surgical Risk Assessment and Communication358MIPS CQM0.32 - 4.824.83 - 54.8154.82 - 97.3597.36 - 99.99100   
Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies360MIPS CQM0.3 - 2.662.67 - 9.89.81 - 98.8998.9 - 99.99100   
Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines364MIPS CQM1.05 - 54.4254.43 - 75.8275.83 - 91.7991.8 - 99.99------100
Follow-Up Care for Children Prescribed ADHD Medication (ADD)366eCQM1.74 - 10.4310.44 - 15.2815.29 - 26.426.41 - 35.4435.45 - 49.4749.48 - 74.4174.42 - 90.53>=90.54
Depression Remission at Twelve Months370MIPS CQM----------------
Depression Remission at Twelve Months370eCQM0.54 - 1.411.42 - 2.932.94 - 6.997 - 16.7816.79 - 31.7431.75 - 48.448.41 - 64.91>=64.92
Closing the Referral Loop: Receipt of Specialist Report374eCQM0.23 - 2.622.63 - 10.4610.47 - 37.6937.7 - 68.1968.2 - 90.1890.19 - 97.4297.43 - 99.99100
Closing the Referral Loop: Receipt of Specialist Report374MIPS CQM1.13 - 5.895.9 - 51.7551.76 - 96.1996.2 - 99.99------100
Functional Status Assessment for Total Knee Replacement375eCQM0.33 - 1.481.49 - 3.113.12 - 14.9915 - 45.6345.64 - 75.1375.14 - 85.5485.55 - 98.15>=98.16
Functional Status Assessment for Total Hip Replacement376eCQM0.55 - 1.641.65 - 4.995 - 17.7617.77 - 39.9940 - 68.9969 - 83.0683.07 - 91.16>=91.17
Functional Status Assessments for Congestive Heart Failure377eCQM0.04 - 0.80.81 - 1.411.42 - 4.14.11 - 8.558.56 - 16.3116.32 - 21.5421.55 - 55.45>=55.46
Children Who Have Dental Decay or Cavities378eCQM5.57 - 2.192.18 - 1.371.36 - 0.360.35 - 0.01------0
Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists379eCQM0 - 0.050.06 - 0.30.31 - 2.42.41 - 5.535.54 - 11.2211.23 - 18.2118.22 - 25.52>=25.53
Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment382eCQM0.22 - 1.481.49 - 9.859.86 - 27.9527.96 - 53.4753.48 - 83.4183.42 - 93.9693.97 - 99.99100
Adherence to Antipsychotic Medications For Individuals with Schizophrenia383MIPS CQM8.74 - 39.3239.33 - 79.4379.44 - 98.8398.84 - 99.99------100
Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery384MIPS CQM67.73 - 91.4591.46 - 99.99----------100
Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery385MIPS CQM----------------
Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences386MIPS CQM----------------
Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users387MIPS CQM----------------
Cataract Surgery: Difference Between Planned and Final Refraction389MIPS CQM0.1 - 0.440.45 - 0.810.82 - 1.481.49 - 3.213.22 - 93.7493.75 - 99.99--100
Hepatitis C: Discussion and Shared Decision Making Surrounding Treatment Options390MIPS CQM4.64 - 37.937.91 - 69.4669.47 - 99.99--100   
Follow-Up After Hospitalization for Mental Illness (FUH)391MIPS CQM----------------
Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation392MIPS CQM----------------
Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision393MIPS CQM----------------
Immunizations for Adolescents394MIPS CQM0.55 - 1.992 - 4.274.28 - 13.7813.79 - 23.823.81 - 36.4136.42 - 46.3646.37 - 60.94>=60.95
Lung Cancer Reporting (Biopsy/Cytology Specimens)395Medicare Part B Claims92.37 - 99.99------100   
Lung Cancer Reporting (Biopsy/Cytology Specimens)395MIPS CQM53.87 - 99.6199.62 - 99.99----100   
Lung Cancer Reporting (Resection Specimens)396Medicare Part B Claims----------------
Lung Cancer Reporting (Resection Specimens)396MIPS CQM70.78 - 99.99------100   
Melanoma Reporting397Medicare Part B Claims96.56 - 99.99------100   
Melanoma Reporting397MIPS CQM3.33 - 91.1591.16 - 99.99----100   
Optimal Asthma Control398MIPS CQM0.68 - 20.3820.39 - 44.444.41 - 84.5784.58 - 99.99------100
One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk400MIPS CQM0.13 - 0.370.38 - 1.261.27 - 3.893.9 - 46.3746.38 - 87.6787.68 - 99.99--100
Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis401MIPS CQM----------------
Tobacco Use and Help with Quitting Among Adolescents402MIPS CQM24.3 - 77.3477.35 - 90.3790.38 - 97.0597.06 - 99.9199.92 - 100   
Anesthesiology Smoking Abstinence404MIPS CQM7.52 - 36.2436.25 - 51.7851.79 - 69.5469.55 - 85.1285.13 - 97.397.31 - 99.7799.78 - 99.99100
Appropriate Follow-up Imaging for Incidental Abdominal Lesions405MIPS CQM----------------
Appropriate Follow-up Imaging for Incidental Abdominal Lesions405Medicare Part B Claims----------------
Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients406Medicare Part B Claims81.33- 31.5733.56 - 4.884.87 - 0.01--------0
Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients406MIPS CQM66.08 - 29.9129.9 - 16.9216.91 - 4.534.52 - 0.01------0
Opioid Therapy Follow-up Evaluation408MIPS CQM0.38 - 29.5929.6 - 74.9975 - 98.998.91 - 99.99100   
Clinical Outcome Post Endovascular Stroke Treatment409MIPS CQM----------------
Psoriasis: Clinical Response to Systemic Medications410MIPS CQM1.81 - 15.0215.03 - 42.942.91 - 76.7176.72 - 96.696.61 - 99.99----100
Documentation of Signed Opioid Treatment Agreement412MIPS CQM0.97 - 40.9140.92 - 76.6976.7 - 99.99--100   
Door to Puncture Time for Endovascular Stroke Treatment413MIPS CQM----------------
Evaluation or Interview for Risk of Opioid Misuse414MIPS CQM4.64 - 59.5459.55 - 96.3296.33 - 99.99--100   
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older415MIPS CQM34.04 - 58.2458.25 - 72.2172.22 - 93.5493.55 - 99.5399.54 - 99.99----100
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years416MIPS CQM65.88 - 44.2944.28 - 40.8240.81 - 30.4830.47 - 15.6315.62 - 2.392.38 - 0.01--0
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years416Medicare Part B Claims----------------
Osteoporosis Management in Women Who Had a Fracture418Medicare Part B Claims----------------
Osteoporosis Management in Women Who Had a Fracture418MIPS CQM0.52 - 2.032.04 - 3.33.31 - 9.519.52 - 39.1139.12 - 89.6489.65 - 99.99--100
Overuse of Imaging for the Evaluation of Primary Headache419Medicare Part B Claims----------------
Overuse of Imaging for the Evaluation of Primary Headache419MIPS CQM----------------
Varicose Vein Treatment with Saphenous Ablation: Outcome Survey420MIPS CQM----------------
Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal421MIPS CQM----------------
Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury422MIPS CQM----------------
Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury422Medicare Part B Claims----------------
Perioperative Temperature Management424MIPS CQM48.43 - 91.6891.69 - 98.8898.89 - 99.8499.85 - 99.99100   
Photodocumentation of Cecal Intubation425Medicare Part B Claims----------------
Photodocumentation of Cecal Intubation425MIPS CQM----------   
Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy429Medicare Part B Claims----------------
Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy429MIPS CQM----------------
Prevention of Post-Operative Nausea and Vomiting (PONV) - Combination Therapy430MIPS CQM31.65 - 87.8287.83 - 96.4296.43 - 99.2599.26 - 99.9799.98 - 100   
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling431MIPS CQM0.22 - 11.3711.38 - 44.8744.88 - 81.5681.57 - 97.1697.17 - 99.99----100
Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair432MIPS CQM1.73 - 0.970.96 - 0.01----------0
Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair433MIPS CQM1.12 - 1.021.01 - 0.410.4 - 0.01--------0
Proportion of Patients Sustaining a Ureter Injury at the Time of Pelvic Organ Prolapse Repair434MIPS CQM----------------
Quality of Life Assessment For Patients With Primary Headache Disorders435Medicare Part B Claims----------------
Quality of Life Assessment For Patients With Primary Headache Disorders435MIPS CQM0.78 - 3.543.55 - 7.787.79 - 49.0749.08 - 99.99------100
Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques436Medicare Part B Claims2.36 - 90.1790.18 - 98.4898.49 - 99.8999.9 - 99.99100   
Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques436MIPS CQM0.84 - 85.1585.16 - 98.3698.37 - 99.9199.92 - 99.99100   
Rate of Surgical Conversion from Lower Extremity Endovascular Revascularization Procedure437Medicare Part B Claims3.91 - 3.583.57 - 2.952.94 - 2.032.02 - 0.01------0
Rate of Surgical Conversion from Lower Extremity Endovascular Revascularization Procedure437MIPS CQM19.09 - 9.439.42 - 6.416.4 - 0.350.34 - 0.01------0
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease438eCQM3.54 - 42.1942.2 - 60.5560.56 - 69.8269.83 - 77.1277.13 - 83.583.51 - 86.286.21 - 95.54>=95.55
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease438MIPS CQM32.72 - 64.8264.83 - 76.2176.22 - 91.6591.66 - 99.99------100
Age Appropriate Screening Colonoscopy439MIPS CQM74.22 - 43.3743.36 - 30.3930.38 - 0.01--------0
Skin Cancer: Biopsy Reporting Time - Pathologist to Clinician440MIPS CQM6.94 - 92.0892.09 - 99.1599.16 - 99.99--100   
Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)441MIPS CQM1.7 - 20.8220.83 - 40.440.41 - 58.9758.98 - 6969.01 - 77.3677.37 - 81.7281.73 - 87.39>=87.4
Non-Recommended Cervical Cancer Screening in Adolescent Females443MIPS CQM11.39 - 7.17.09 - 3.493.48 - 2.32.29 - 0.01------0
Medication Management for People with Asthma444MIPS CQM14.57 - 57.1957.2 - 77.3477.35 - 96.6596.66 - 99.99100   
Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)445MIPS CQM10.32 - 6.96.89 - 5.095.08 - 2.912.90 - 1.871.86 - 0.650.64 - 0.01--0
Appropriate Workup Prior to Endometrial Ablation448MIPS CQM----------------
Trastuzumab Received By Patients With AJCC Stage I (T1c) - III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy450MIPS CQM----------------
RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy451MIPS CQM----------------
Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies452MIPS CQM----------------
Percentage of Patients Who Died from Cancer Receiving Chemotherapy in the Last 14 Days of Life (lower score - better)453MIPS CQM36.53 - 24.0124 - 20.0120 - 16.0116 - 10.0110 - 6.136.12 - 4.354.34 - 3.32<= 3.31
Percentage of Patients Who Died from Cancer Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life (lower score - better)455MIPS CQM----------------
Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score - better)457MIPS CQM24.9 - 20.5220.51 - 18.7818.77 - 14.9614.95 - 10.0110 - 5.515.5 - 3.543.53 - 2.89<= 2.88
All-cause Hospital Readmission458Administrative Claims----------------
Back Pain After Lumbar Discectomy/Laminectomy459MIPS CQM----------------
Back Pain After Lumbar Fusion460MIPS CQM----------------
Leg Pain After Lumbar Discectomy/Laminectomy461MIPS CQM----------------
Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy462eCQM----------------
Prevention of Post-Operative Vomiting (POV) - Combination Therapy (Pediatrics)463MIPS CQM58.58 - 91.1791.18 - 95.6995.7 - 98.5698.57 - 99.99------100
Otitis Media with Effusion: Systemic Antimicrobials - Avoidance of Inappropriate Use464MIPS CQM70.38 - 80.6380.64 - 88.1288.13 - 94.7994.8 - 98.1698.17 - 99.99----100
Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries465MIPS CQM----------------
Continuity of Pharmacotherapy for Opioid Use Disorder (OUD)468MIPS CQM----------------
Functional Status After Lumbar Fusion469MIPS CQM----------------
Functional Status After Primary Total Knee Replacement470MIPS CQM----------------
Functional Status After Lumbar Discectomy/Laminectomy471MIPS CQM----------------
Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture472eCQM----------------
Leg Pain After Lumbar Fusion473MIPS CQM----------------
HIV Screening475eCQM----------------
International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia476eCQM----------------
Multimodal Pain Management477MIPS CQM----------------
Functional Status Change for Patients with Neck Impairments478MIPS CQM----------------

Register with MDinteractive